|
All Demyelinating disease (CNS)
Citations 61-70 of 85 total displayed.
|
Past content
(since Jan 2001):
|
- ARTICLES
New diagnostic criteria for multiple sclerosis: Application in first demyelinating episode
- M. Tintoré, A. Rovira, J. Río, C. Nos, E. Grivé, J. Sastre-Garriga, I. Pericot, E. Sánchez, M. Comabella, and X. Montalban
Neurology 2003; 60: 27-30.
[Abstract]
[Full text]
[PDF]
- SPECIAL ARTICLES
Immunization and MS: A summary of published evidence and recommendations
- Olivier T. Rutschmann, Douglas C. McCrory, and David B. Matchar
Neurology 2002; 59: 1837-1843.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
A severe variant of childhood ataxia with central hypomyelination/vanishing white matter leukoencephalopathy related to EIF21B5 mutation
- A. Fogli, C. Dionisi-Vici, F. Deodato, A. Bartuli, O. Boespflug-Tanguy, and E. Bertini
Neurology 2002; 59: 1966-1968.
[Abstract]
[Full text]
[PDF]
- CLINICAL/SCIENTIFIC NOTES
Transient cerebral white matter lesions in a patient with connexin 32 missense mutation
- H.J. Schelhaas, B.G.M. van Engelen, A.A.W.M. Gabreëls-Festen, G. Hageman, J.H.R. Vliegen, M.S. van der Knaap, and M.J. Zwarts
Neurology 2002; 59: 2007-2008.
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Adult onset glutaric aciduria type I presenting with a leukoencephalopathy
- O. Bähr, I. Mader, J. Zschocke, J. Dichgans, and J.B. Schulz
Neurology 2002; 59: 1802-1804.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
The chemokine receptor CCR5 deletion mutation is associated with MS in HLA-DR4–positive Russians
- O. O. Favorova, T. V. Andreewski, A. N. Boiko, M. A. Sudomoina, A. D. Alekseenkov, O. G. Kulakova, A. V. Slanova, and E. I. Gusev
Neurology 2002; 59: 1652-1655.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
CNS demyelination associated with copper deficiency and hyperzincemia
- C.I. Prodan, N.R. Holland, P.J. Wisdom, S.A. Burstein, and S.S. Bottomley
Neurology 2002; 59: 1453-1456.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Acute disseminated encephalomyelitis: A long-term follow-up study of 84 pediatric patients
- Silvia Tenembaum, Nestor Chamoles, and Natalio Fejerman
Neurology 2002; 59: 1224-1231.
[Abstract]
[Full text]
[PDF]
- EDITORIALS
Cholesterol-lowering statins possess anti-inflammatory activity that might be useful for treatment of MS
- Scott S. Zamvil and Lawrence Steinman
Neurology 2002; 59: 970-971.
[Full text]
[PDF]
- ARTICLES
Statins as immunomodulators: Comparison with interferon-ß1b in MS
- O. Neuhaus, S. Strasser-Fuchs, F. Fazekas, B.C. Kieseier, G. Niederwieser, H.P. Hartung, and J.J. Archelos
Neurology 2002; 59: 990-997.
[Abstract]
[Full text]
[PDF]
|
|
